COVID-19 vaccine dry run in all states and union territories on Jan 2

After successfully concluding the Coronavirus vaccination dry run in four states a similar megadrill will be conducted in all states and union territories on January 2This is aimed at equipping the entire administration and management of vaccine supply storage and logistics including cold chain management the Health Ministry said on ThursdayThe activity is proposed to be conducted in all state capitals in at least three session sites Some states will also include districts that are situated in difficult terrain or have poor logistical supportMaharashtra and Kerala are likely to schedule the dryrun in major cities other than their capitalThe objective of the dry run for COVID19 vaccine introduction is to assess operational feasibility in the use of CoWIN application in field environment to test the linkages between planning and implementation and to identify the challenges and guide way forward prior to actual implementation the ministry addedFor each of the three session sites the concerned medical officer Incharge will identify 25 test beneficiaries healthcare workers The States and UTs have been asked to ensure that the data of these beneficiaries is uploaded in CoWINThese beneficiaries will also be available at the session site for the dry run The States and UTs have also been asked to prepare the facilities and users to be created on CoWIN application including uploading the data of Health Care Worker HCW beneficiariesThe States and UTs have been directed to ensure physical verification of all proposed sites for adequacy of space logistical arrangements Internet connectivity electricity safetyThey have been asked to prepare at least three model session sites in each State for demonstration ensure that the Model Sites have separate entry and exit in a threeroom setup with adequate space outside for awareness generation activities display all IEC material at these sitesAs the vaccine administrators will play an important role in the vaccination process training of trainers and those who shall administer the vaccine has been taken up across various states Around 96000 vaccinators have been trained for this purposeAbout 2360 participants have been trained in National Training of Trainers and over 57000 participants trained in District level training in 719 districts States are augmenting the State helpline 104 which shall be used in addition to 1075 for any vaccine and software related queryOrientation and capacity building of the Call Centre executives has taken place in the States and UTs States were also encouraged to use the FAQs issued by the Health Ministry proactively to address any such queryAn important focus of the dry run will be on management of any possible adverse events following immunisation AEFI In addition adherence and management of infection control practices at the session site to prevent disease transmissionThe mock drill will include concurrent monitoring and review at the block and district levels and preparation of feedback The State Task Force shall review the feedback and share with the Union Health MinistryOn December 28 and 29 dry run for the Covid19 vaccination was conducted in Krishna district of Andhra Pradesh Rajkot and Gandhinagar district of Gujarat Ludhiana and Shaheed Bhagat Singh Nagar of Punjab and Sonitpur and Nalbari districts of AssamAfter a year which saw an unprecedented global health crisis many are anticipating the coronavirus vaccine as India prepares for the inoculation campaign which is likely to commence in January 2021The central government plans to vaccinate nearly 30 crore people in the first phase of drive It will be offered to one crore healthcare workers along with 2 crore frontline and essential workers and 27 crore elderly mostly above the age of 50 years with comorbiditiesIndia currently has eight Covid19 vaccine candidates including three indigenous vaccines under different stages of clinical trials which could be ready for authorisation in near future Serum InstituteOxfords Covishield Bharat Biotechs Covaxin and Pfizer vaccine are in the fray for emergency use authorisationThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever